帕瑞昔布钠复合吗啡对腹部手术患者自控镇痛及呼吸功能的影响

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (3): 308-312.

帕瑞昔布钠复合吗啡对腹部手术患者自控镇痛及呼吸功能的影响

孙立新, 丛丽, 时飞, 王明山

青岛市市立医院东院麻醉科,青岛 266071,山东

收稿日期:2011-01-14 修回日期:2011-02-12 出版日期:2011-03-26 发布日期:2011-05-18
作者简介:孙立新,男,硕士,主治医师,主要从事临床麻醉与镇痛工作。Tel: 13697686927 E-mail: sunlixin1221@sina.com

Effects of analgesia with parecoxib combined morphine on patient controlled analgesia and pulmonary function in patients after abdominal opertion

SUN Li-xin, CONG Li, SHI Fei, WANG Ming-shan

Department of Anesthesiology, Qingdao Municipal Hospital, Qingdao 266071,Shandong,China

Received:2011-01-14 Revised:2011-02-12 Online:2011-03-26 Published:2011-05-18

摘要/Abstract

摘要： 目的: 观察帕瑞昔布钠复合吗啡对拟行腹部手术患者自控镇痛及呼吸功能的影响。方法: 将50例拟行腹部手术患者随机分为帕瑞昔布钠组(P组)和吗啡组(M组),每组25例。PCA泵的镇痛药为吗啡 1 mg/mL,应用PCA泵的同时,P组静脉注射首剂帕瑞昔布钠 40 mg,首剂药物后12、24和 36 h,静脉注射帕瑞昔布钠 40 mg;M组在4时间点均注射生理盐水。镇痛开始后12、24、36和 48 h 记录疼痛VAS评分及镇静程度评分;PCA需求按压次数、有效按压次数及药物用量;术后各种并发症及不良反应发生率;术后24、48和 72 h 呼吸功能指标。结果: P组患者各时间点安静痛和咳嗽痛评分显著低于M组(P<0.05);镇静程度评分、PCA需求按压次数、有效按压次数及药物用量P组显著低于M组(P<0.05);P组恶心发生率显著低于M组(P<0.05);P组术后24、48 h 的FVC%和FEV₁%明显高于M组(P＜0.05),术后 24 h 动脉血二氧化碳分压(PaCO₂)明显低于M组(P＜0.05)。结论: 帕瑞昔布钠可安全有效地应用于拟行腹部手术患者自控镇痛,可减少吗啡用量并有利于呼吸功能恢复。

关键词: 帕瑞昔布钠, 吗啡, 疼痛,患者控制, 呼吸功能

Abstract: AIM: To investigate effects of analgesia with parecoxib combined morphine on patient controlled analgesia and pulmonary function in patients after abdominal opertion.METHODS: Fifty patients were randomly allocated to Parecoxib group (group P, n=25) and Morphine group (group M, n=25). Both group received PCA with morphine (1 mg/mL) . Group P received intravenous parecoxib 40 mg while the PCA pump beginning, 12,24 and 48 h after the first dose. Group M received intravenous normal saline at the same four point. The following indexes were recorded at 12, 24, 36 and 48 hours after the PCA pumps were used: VAS scores of pain, sedation score, demanded delivery, effective delivery, drug dose, and side effects. To compare parameters of pulmonary function in postoperative 24,48 and 72 h between the two groups.RESULTS: Compared with group M , there were significant decreases in VAS scores of pain at 12, 24, 36 and 48 hours after the PCA pumps were used(P<0.05). Sedation score, demanded delivery, effective delivery and drug dose in group P were obviously lower than those in group M(P<0.05). The incidence rate of nausea in group P was obviously lower than that in group M(P<0.05). FVC% and FEV1% were significantly higher in postoperative 24 and 48 h in treatment group than those in control group (P<0.05). PaCO₂ were significantly lower in postoperative 24 h in treatment group than that in control group (P<0.05).CONCLUSION: Parecoxib can relief pain in patient after abdominal opertion safely and efficiently, reduce the morphine consumption and improve pulmonary function.

Key words: Parecoxib Sodium, Morphine , Analgesia, patient-controlled , Pulmonary function

中图分类号:

R614

孙立新, 丛丽, 时飞, 王明山. 帕瑞昔布钠复合吗啡对腹部手术患者自控镇痛及呼吸功能的影响[J]. 中国临床药理学与治疗学, 2011, 16(3): 308-312.

SUN Li-xin, CONG Li, SHI Fei, WANG Ming-shan. Effects of analgesia with parecoxib combined morphine on patient controlled analgesia and pulmonary function in patients after abdominal opertion[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 308-312.

参考文献

[1] Apfelbaum JL, Desjardins PJ, Brown MT, et al. Multiple-day efficacy of parecoxib sodium treatment in postoperative bunionectomy pain[J].Clin J Pain, 2008, 24(9): 784-792.
[2] Viscusi ER, Gimbel JS, Halder AM, et al. A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty[J]. Anesth Analg, 2008, 107(2): 652-660.
[3] Gierse JK, McDonald JJ, Hauser SD, et al. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors[J]. J Biol Chem,1996, 271(26): 15810-15814.
[4] 赵晶,叶铁虎,罗爱伦.镇痛药物及其应用[J].中国临床康复,2002,6(16): 2350-2352.
[5] Hubbard RC, Naumann TM, Traylor L, et al. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia[J]. Br J Anaesth, 2003, 90(2):166-172.
[6] Gross JB. Parecoxib sodium, a parenteral cyclooxygenase-2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty[J]. Surv Anesthesiol, 2004, 48(2):99-100.
[7] 吴新民,岳云,张利萍,等. 术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性[J].中华麻醉学杂志, 2007,27(1):7-10.
[8] 陈忠华,蒋宗明,楼静芝,等.帕瑞昔布钠超前镇痛对胃癌根治术患者围术期Th1 / Th2 平衡的影响[J]. 中国临床药理学与治疗学, 2010,15(6):686-690.
[9] 施文,王永铭,程能能,等.非甾体类抗炎药的不良反应研究进展[J].中国临床药理学杂志,2003,19(1):59-61.
[10] Ott E, Nussmeier NA, Duke PC, et al. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery[J]. J Thorac Cardiovasc Surg, 2003,125(6):1481-1492.

[1]	衡冰冰，戴舒阳，杨丹峰，Beekoo Deepti，连庆泉，上官王宁. 丙泊酚对吗啡鞘内注射所致瘙痒大鼠脊髓内胃泌素释放肽受体的影响[J]. 中国临床药理学与治疗学, 2019, 24(7): 759-765.
[2]	何建国，袁立勇，陈林，姜娟. 帕瑞昔布钠在小儿腹腔镜阑尾切除术中的超前镇痛作用[J]. 中国临床药理学与治疗学, 2017, 22(6): 705-708.
[3]	王钊，衡冰冰，杨丹峰，赵鸿雁，李军，连庆泉，上官王宁. 丙泊酚对吗啡鞘内注射所致瘙痒大鼠背根神经节中瞬时电位香草酸受体亚型1的影响[J]. 中国临床药理学与治疗学, 2016, 21(8): 848-853.
[4]	程小春, 张森, 黄军, 汪伟伟, 刘伟, 汪萌芽. 单次吗啡暴露差异性增强大鼠杏仁核和伏隔核的吗啡敏感性[J]. 中国临床药理学与治疗学, 2015, 20(9): 998-1003.
[5]	钱祖超, 张群, 罗华梁. 盐酸羟考酮用于腹腔镜直肠癌根治术患者镇痛效果的观察[J]. 中国临床药理学与治疗学, 2015, 20(5): 587-590.
[6]	顾钧, 徐泽民, 符丹, 周文华, 杨国栋. 东莨菪碱对吗啡诱导大鼠伏核多巴胺释放的调节作用[J]. 中国临床药理学与治疗学, 2015, 20(10): 1087-1091.
[7]	程向阳, 宗巧凤, 胡杰, 高琴, 李正红. 内吗啡肽-1对麻醉大鼠左心室功能的影响[J]. 中国临床药理学与治疗学, 2014, 19(8): 872-876.
[8]	曲丕盛, 付霜, 黄丽霞, 王振, 陶凡, 郑汉光. 腹腔神经丛阻滞术对胰腺癌患者吗啡药物用量的影响[J]. 中国临床药理学与治疗学, 2014, 19(5): 557-560.
[9]	戴志远, 郑芳, 李德强. 度洛西汀与硫酸吗啡联合治疗癌痛的临床观察[J]. 中国临床药理学与治疗学, 2013, 18(10): 1138-1143.
[10]	吕庆琴, 陈霆隽, 洪炎国. μ阿片受体的内吞抑制吗啡耐受的形成[J]. 中国临床药理学与治疗学, 2012, 17(10): 1185-1190.
[11]	吴平蕾. 帕瑞昔布钠对外科腰麻患者术后镇痛和不良反应的影响[J]. 中国临床药理学与治疗学, 2011, 16(11): 1292-1296.
[12]	陈忠华, 蒋宗明, 楼静芝, 郑羡河, 张昌锋, 胡双燕, 樊菊美. 帕瑞昔布钠超前镇痛对胃癌根治术患者围术期Th1/Th2平衡的影响[J]. 中国临床药理学与治疗学, 2010, 15(6): 686-690.
[13]	杜金, 黄宇光. 急性阿片耐受大鼠脊髓NMDA受体NR2A及NR2B亚基表达的改变[J]. 中国临床药理学与治疗学, 2010, 15(1): 59-65.
[14]	赵永娜, 方正梅, 邵晓霞, 李晓红, 李顺英. 大鼠相关脑区p-CREB 和c-Fos在吗啡点燃条件性位置偏爱条件下的变化[J]. 中国临床药理学与治疗学, 2009, 14(1): 10-13.
[15]	熊波, 史琪清, 王炫. 罗哌卡因局部浸润对小儿阑尾手术后疼痛的影响[J]. 中国临床药理学与治疗学, 2008, 13(5): 573-577.